1,300
Participants
Start Date
March 31, 2014
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2018
Vitamin D3 (cholecalciferol)
The intervention is an oral tablet containing vitamin D3 (cholecalciferol). This vitamin D supplement will be provided in the form of small tablets (approximately 10 mm diameter) and will be custom- manufactured by Toronto Institute for Pharmaceutical Technology (TIPT) in Toronto, Ontario, Canada. Each weekly dose will consist of a single tablet. Across trial groups, the tablets will only vary with respect to the vitamin D3 dose, as described above.
Placebo
This product will be identical in appearance, taste and texture to the experimental formulation but will not include any vitamin D3.
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER
Shimantik
UNKNOWN
Bill and Melinda Gates Foundation
OTHER
The Hospital for Sick Children
OTHER